You have an opportunity to in-license a product, but you want to check with payors, KOLs, and/or practicing clinicians to best evaluate the opportunity. At SKIM we have developed an approach that meets any requirement you might have. Whenever you need a quick and cost-effective market landscape, we can provide you with great answers.

Licensing – a big trend in pharma

In the current pharma environment with in-licensing deals becoming more and more common, SKIM has become an expert in conducting quick market landscaping studies for the purpose of evaluating business development opportunities. The turnaround time on these projects has been three to four weeks from commissioning to final report delivery.

Quick turnaround time

Generally, we speak with prescribing physicians, payors, hospital formulary committee members, and KOLs. We provide our clients with top line results after 3 weeks. Then, based on client feedback, we conduct the remaining handful of interviews, including a few additional questions that might arise during the top-line presentation. This allows us to cover all relevant topics, and focus on the key remaining open questions with the most relevant respondents.

Pascale Malgouyres, Poxel: "There was added value in having an EU-based contact at SKIM, who seamlessly liaised with her US-based colleagues to conduct interviews with American physicians and payors."

Interviews done in house

Many of the interviews have been conducted in English (even in non-English speaking markets), allowing our clients to listen to the interviews and without the added expense of translation. For one particular study, our client commented that “there was added value in having an EU-based contact at SKIM, who seamlessly liaised with her US-based SKIM colleagues to conduct interviews with American physicians and payors.” (Pascale Malgouyres, Poxel)

SKIM's truly global reach

At SKIM we employ people from over 35 countries, have in-house moderators for most of the major EU markets and even some of the smaller countries. Keeping much of the moderation in-house, allows us to quickly make small adaptations to the questionnaire, and continue forward with the project. In the end, we are able to closely monitor the quality of the research and carefully control costs with moderation, project management, and analysis occurring under one roof.

So the next time your company needs a quick and cost-effective market landscape for a new product or indication, you know you can trust SKIM to provide you with great answers.

Want to know more? Don't hesitate to give us a call or drop an email!